cyfluthrin has been researched along with Pneumonia, Bacterial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bukofzer, S; Hammerschlag, MR; Ramirez, J; Reznik, T; Roblin, PM; Summersgill, J | 1 |
| Edelstein, MA; Edelstein, PH; Higa, F | 1 |
1 trial(s) available for cyfluthrin and Pneumonia, Bacterial
| Article | Year |
|---|---|
Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
Topics: Adult; Aged; Chlamydia Infections; Chlamydophila pneumoniae; Double-Blind Method; Erythromycin; Female; Humans; Ketolides; Male; Microbial Sensitivity Tests; Middle Aged; Nasopharynx; Pneumonia, Bacterial; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
1 other study(ies) available for cyfluthrin and Pneumonia, Bacterial
| Article | Year |
|---|---|
In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
Topics: Animals; Colony Count, Microbial; Disease Models, Animal; Erythromycin; Guinea Pigs; Ketolides; Legionella pneumophila; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Outcome | 2001 |